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Summary 
This report of the National Reference Laboratory (NRL) for residues of veterinary drugs in products of 
animal origin according to 96/23/EC describes the activities employed in 2006 and 2007. 
The communication with routine field laboratories (RFL), the preparation of quality control samples for 
RFL and the advisory function for the competent authority and RFL arc the main tasks of the NRL. 
Communication and advices 
In the period 2006/2007 the NRL organized 5 official meetings with RFL (minutes arc available) and 
several times informal meetings by telephone and e-mails. The competent authority was advised on two 
different issues viz. the use of hair as a test matrix for unauthorized compounds and (on request of the 
competent authority) on the method of analysis used by a private lab for the control of milk and milk 
products. Furthermore the NRL participated in an EU meeting. The objective of the meeting was to 
collect information on how the control of antibiotics in milk is organized within the different member 
states. 
Coordinating activities 
The NRL prepared quality control samples (approximately 155 samples for 11 different analyses). The 
NRL provided the RFL with 9 new methods of analysis and advised 3 times NRLs outside the 
Netherlands - on their request - about different methods of analysis for the determination of veterinary 
drugs. 
Participation in workshops and proficiency tests 
Employees of the NRL participated in workshops (5 times) and proficiency tests (5 times) organized by 
community reference laboratories. NRL employees participated also in 11 proficiency tests organized by 
other organizations like FAPAS. The results of the proficiency tests (except one) were all acceptable (Z-
score <2). 
In 2006 RIKILT was accredited (according to ILAC G 13:2000) for the organization of proficiency tests. 
Three (inter)national proficiency tests were organized by RIKILT. 
Finally, several scientific papers were written, posters presented and lectures given on trends in the 
analysis of veterinary drugs and growth promoting agents. The construction of a RIKILT-NRL website 
was initiated. For the coming period this web-site will be extended and collaboration and communication 
of the NRL and RFLs will be continued. Special attention will be paid to the quality assurance procedures 
like control/checks of (commercially) available reference standards. 
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1 Introduction 
The European Commission is committed to protecting consumers from intolerable health hazards, which 
may be associated with residues of veterinary drugs or even of non-licensed or forbidden substances in 
animal products intended for human consumption. For this purpose legislation on veterinary drug residue 
control has been established as the indispensable basis of the consumer protection within the EU. The 
European residue legislation commits the Member States to establish a national residue control plan and 
provides for the establishment of a hierarchically structured system of Community reference laboratories 
(CRLs), national reference laboratory (NRLs) and routine field laboratories (RFLs). 
The responsibilities of the NRL are described in 96/23/EC and included the following items: 
• coordinating the work of the other NRLs responsible for residue analysis, in particular by 
coordinating the standards and methods of analysis for each residue or residue group concerned, 
assisting the competent authority in organizing the plan for monitoring residues, 
periodically organizing comparative tests for each residue or reside group assigned to them, 
ensuring that national laboratories observe the limits laid down, 
disseminating information supplied by the CRLs, 
ensuring that their staff are able to take part in further training courses organized by the Commission 
or by Commission reference laboratories. 
This report describes the activities of the NRL for veterinary drugs according to EU document 96/23/ EU. 
It covers the groups of compounds assigned to RIKILT-NRL regarding veterinary health viz. nitrofurans, 
dapson, nitroimidazoles, chloroform, antibiotics (including sulphonamides, quinolones, tetracyclines), 
anthelmintics, carbamates, pyrethroids, coccidostats, non-steroidal antiinflammatory drugs (NSAIDs), 
organochlorine compounds (including PCBs), organophosphorous compounds and dioxins. These groups 
belong to Group A6, Group Bl, B2 (a, b, c, e), B3 (a, b, 0 compounds as described in EU document 
96/23/EC. 
The activities employed in 2007 regarding the Group B2 (c) compounds (carbamates and pyrethroids) and 
the Group B3 compounds (organochlorine compounds including PCBs, organophosphorus compounds 
and dioxins) will be reported seperately. 
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2 Communications and advices 
One of the tasks of the NRL is to communicate with the Competent Authority, Routine Field Laboratories 
and other NRL on issues regarding the control of residues of veterinary drugs. Sometimes the 
communication is on a regular base and sometimes ad hoc. The same is applicable to the advices given by 
the NRL. Sometimes advice is requested and sometimes advice is given. The communication and advice 
activities employed by the NRL in 2006/2007 are described below. 
2.1 Communications 
2.1.1 With competent authority 
On a regular base there is meeting between the competent authority The Ministery of Agriculture, Nature 
and Food Quality on the content of the National Monitoring Plans. 
In 2006/2007 RIKILT participated in the following national platforms: 
• policy working group plan for monitoring residues 
• policy working group dioxins (since 2007 different RIKILT-NRL project). 
2.1.2 With Routine Field Laboratory (Food and Consumer Product Safety Authority, 
Laboratory Region East) 
On a regular base the management of RIKILT communicate with the management of the Food and 
Consumer Product Safety Authority, Laboratory Region East (in this report referred to as VWA-East). 
On a regular base the analytical technicians of RIKILT communicate with the technicians of VWA-East. 
Sec also item 3.1.1. 
2.1.3 With National Reference Laboratory 
On a regular base the management of the national reference laboratories in the field of veterinary health 
viz. RIVM and RIKILT meets with the management of VWA-East in the so called R3 meeting. During 
these meetings the analytical activities are discussed and there is an exchange of information and 
experiences. Furthermore within the R3 meeting the requests for proficiency tests arc being discussed and 
proficiency tests planned. Next to the R3 meetings on a regular bases the activities in the field of 
veterinary drugs analysis regarding the technical innovations and trends are discussed in the Q3 (Quality, 
Control, Quartet). In the Q3 participate the R3 laboratories and TNO. 
In 2007 the R3 group had a meeting on June 26 (meeting No. 72) in Wageningen/RIKILT and on October 
31 (meeting No. 73) 2007 in Bilthoven/RIVM. From these meetings minutes were made by respectively 
RIKILT and RIVM. The participants were RIVM, RIKILT and VWA-East. 
In 2006 the Q3 group had a meeting on September 20 (meeting No. 106). From these meeting minutes 
were made by RIVM and send to the other participants RIKILT, VWA-East and TNO. 
In 2007 the Q3 group had a meeting on June 26 (meeting No. 107) in Wageningen and on October 31 
(meeting No. 108) 2007 in Bilthovcn. From these meetings minutes were made by respectively RIKILT 
and RIVM. The participants were RIVM, RIKILT, VWA-East and TNO. 
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2.2 Advices 
2.2.1 To EU regarding the use of hair for control of beta-agonist 
On the occasion of the Residue Expert Meeting in May 2007 a revised document was made available 
(SANCO 2006/3228) which contains some particular statements regarding the use of hair as a matrix for 
the analysis of beta-agonist. The statement was that hair can be used for screening purposes only. The 
Dutch laboratories involved in residue analysis of veterinary drugs in products of animal origin disagreed 
with this statement. Based on the information from the Dutch NRL/CRL laboratories, the Dutch 
Competent Authority ( VWA) had send a letter to the European Commission informing them about this 
disagreement. This letter is presented in Annex I. 
2.2.2 To EU regarding monitoring antibiotics in milk 
A meeting/workshop was organized by the European Commission, (DG Health and Consumers Protection 
E3). The meeting was the last one of a series of discussions that the Commission had organised with 
different stakeholders involved in the control of residues of antibiotics: i.e. European dairy federations 
and producers of kits for the screening of antibiotics. The objective of the meeting was to collect 
information on how the control of antibiotics is performed in the different levels, farm, collecting tanks, 
dairies industry autocontrols and official controls in the laboratories and to reflect on the different 
strategies followed. 
The meeting took place on April 27, 2007 Brussels Conference Centre Albert Borschette Rue, Froissart 
36 (time 10.00 H-18.00 H). Participants of RIKILT M. Pikkemaat (microbiologist) and A.A.M. Stoiker 
(Chemist). Information was given to the EU by the RIKILT participants regarding the approach of the 
Netherlands regarding the control of milk (based on the questionnaire send by EU to participants sec 
Annex II). 
2.2.3 To competent authority regarding analysis of triclabendazole in milk 
On request of the competent authority RIKILT has audit the activities of QLIP laboratory regarding the 
analysis of triclabendozole (and metabolites in milk and milk products). The reason for this request was 
some unexpected 'non-conform' results of milk and milk products for triclabendazole were reported by 
QLIP. The competent authority (VWA) asked for technical analytical assistance and advice. 
In November 2007 employees of RIKILT (W. Traag and T. Zuidcma) visited the QLIP facilities and 
audited the triclabendazole research. Special attention was paid to the activities employed by QLIP to 
prevent false positive findings and the quality assurance of the method of analysis used. The observations 
and conclusions are described in a report of RIKILT to VWA of 7 December 2007 (Annex III in dutch). 
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Coordinating activities 
3.1 Preparation of quality control samples 
The activities employed for the routine field laboratory regarding the preparation of quality control 
samples are described in a separate project (WOT programme on Food Safety - Part 3 Veterinary Drugs; 
project 672.037.01 Analytical Chemical Quality Control project for Laboratory VWA-East). The details 
regarding the prepared samples, the analytical results obtained and the discussion/meetings between 
VWA-East and RIKILT are described in RIKILT report 2007.506 of September 2007 'De Chemische 
Borging van Laboratorium VWA door RIKILT Jaarrapportage 2006' by B.J.A. Berendsen and in RIKILT 
report 2008.001 of January 2008 'De Chemische Borging van Laboratorium VWA door RIKILT 
Jaarrapportage 2007' by B.J.A. Berendsen. 
3.2 Providing analytical methods 
On request RIKILT will provide the RFLs with methods of analysis and reference materials. Primary this 
responsibility is focused on the Dutch laboratory (VWA-East), however within the framework of 
collaboration information has been shared with laboratories in Belgium, UK and Germany also. 
In 2006 the following methods have been provided to VWA-East: 
• The analysis of nitroimidazoles in plasma using LC-MS/MS (RSV A1006) 
• The analysis of stanozolol in urine using EI A (RSV A0962) 
• The analysis of aminoglycosides in animal tissues using LC-MS/MS (RSV A1040) 
• The analysis of salmetcrol in hair using LC-MS/MS (RSV A1041) 
The method for the analysis of salmetcrol in hair has also been provided to RIVM, Bilthoven (drs. Saskia 
Sterk) and to FAVV laboratorium, Gent, Belgium (dr. D. Courtheijn). 
In 2007 the following (concept) methods have been provided to VWA-East: 
The analysis of steroids in poultry liver by GC-MS/MS (RSV A1050) 
The analysis of coccidiostatics in egg by LC-MS/MS (concept RSV A 1067) 
The analysis of macrolides in meat by LC-MS/MS (RSV A0690) 
The analysis of Steroidglucuronides in urine by LC-MS/MS (RSV A1030) 
The analysis of the markers of carbadox and olaquindox in meat by LC-MS/MS (RSV A1063) 
Futhermore information regarding the analysis of anabolic steroids by GC-MS was send to Federaal 
Laboratorium voor Voedselveiligheid, Gentbrugge, België (e-mail van 29 June 2007 to 
miekc.vandewiclcufcfavv.be) 
Information regarding the use of ultrafiltration for sample clean-up during analysis of antibiotics from 
animal tissues was send to Central Science Laboratory, York, England (e-mail of 4 June 2007 to 
s. steadies!. gov, uk. 
Information regarding analytical methods available in the Netherlands for thyreostats and beta-agonists in 
blood was send to Kantonales Laboratorium Bern, Switzerland (e-mail of 15 November 2007 to 
susannc.oli vendue f.bc.ch. 
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4 Analytical activities 
The activities employed for the routine field laboratory regarding the development of analytical methods 
to be used in for example the National Monitoring Program residues arc described in a separate project 
(WOT programme on Food Safety - Part 3 Veterinary Drugs; project 671.521.01 Development of methods 
of analysis for the benefit of the execution of the National Plan according to guideline 96/23/EC). The 
details regarding the deliverables arc described in the annual report of the WOT programme on Food 
Safety. 
Regarding the trends in analysis of veterinary drugs a review paper was published with the title 'Trends in 
analysis of veterinary drugs and growth-promoting agents' (authors A.A.M. Stoiker, T. Zuidema and 
M.W.F. Nielen). The article was published in the scientific journal TrAC (november 2007). The abstract is 
presented in Annex IV 
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5 Participating in CRL workshops 
In 2006/2007 employees of RIKILT participated to the following workshops: 
• CRL-Workshop Analytical and Statistical Issues, April 2006, BVL Berlin. 
B.J. A. Berendscn actively contributed to this workshop by means of an oral presentation "An 
improved derivatisation for the analysis of avermectines". 
• CRL-Workshop antibiotics: Strategics of Confirmation Methods, September 2006, AFSSA Fougères. 
J.J.P. Lasaroms actively contributed to this workshop by means of an oral presentation "Advanced 
multi-residue screening in food analysis using UPLC-ToF-MS" 
• CRL-workshop hormones, October 2006, RIVM, Bilthoven 
• CRL-Workshop antibiotics: The Workshop dedicated to a Training Session for the Analysis of Group 
BI Antimicrobial Residues by LCMSMS in muscle tissues and in milk was held at CRL-AFSSA-
LERMVD Fougères on 10-11 October 2007 for 27 experts form the NRLSs of the 27 EU Member 
States. Participant of RIKILT: S.J.W. Stappers. 
• CRL-workshop hormones, 15-17 October 2007, RIVM, Bilthoven including discussions and 
presentations on 
a) new legislation MRL versus MRPL versus RPA 
b) proficiency testing 
c) National Plan activities 
d) analytical methods 
e) mini-symposium on steroid analysis and trends (including protcomics) 
Participants of RIKILT: J.J.P. Lasaroms and A.A.M. Stoiker 
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Participating in proficiency tests 
Due to the scope of the NRL task assigned, RIKILT participated in proficiency tests organized by the 
CRLs, FAPAS and other international organizations: 
In 2006: 
Macrolidcs in honey (FAPAS) 
Estradiol in urine (CRL-RIVM) 
Quinoloncs in muscle of broilers (FAPAS) 
Semicarbazidc in babyfood and egg (JRC-IRMM) 
Tetracyclines standard comparison (FAPAS) 
Nitroimidazoles in muscle (CRL-BVL, Berlijn) 
Quinoloncs standard comparison (FAPAS) 
Nitrofuranes in honey (FAPAS) 
Salmeterol in hair (CRL-RIVM) 
In 2007: 
Pénicillines in meat/liver (RIKILT) 
Sulphonamides in egg (CRL-AFSSA) 
Oxalinic acid in fish (Quasimeme) 
Suphonamides in milk (Progetto Trieste) 
Corticosteroids in urine (Progetto Trieste) 
Synthetic steroids in urine (Progetto Trieste) 
Nitroimidazoles in egg (FAPAS) 
Nitroimidazoles in egg (CRL-BVL) 
For all proficiency tests the Z-scorcs were acceptable (<2) with the exception of oxalinic acid in fish (Z-
score 2.3). The reason for this deviation was that the quantification was not performed on standard 
addition but by the use of a calibration curve in meat. By using the standard addition method the Z-scorc 
was <2. 
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Posters, publications and presentations 
7.1 Posters 
Posters presented at the 5th International Symposium on Hormone and Veterinary Drug Residue Analysis; 
Antwerp, Belgium, 16-19 May 2006: 
• Residue analysis of tetracyclines in poultry muscle; problems revealed by an inter-laboratory study 
Bjom J.A. Berendscn, Angela de Cocq and Hans (J.) A. van Rhijn 
• Can fluorescence detection be considered as a sufficiently conclusive confirmatory method for B-
group substances? 
Tina Zuidema, Patrick P.J. Mulder, Johan J.P. Lasaroms, Stephan Stappers, Hans (J.) A. van Rhijn 
• The occurrence of scmicarbazidc residues in food products: a novel method to discriminate between 
nitrofurazonc and azodicarbonamide use 
Patrick P.J. Mulder, Babette Beumer and Hans (J.) A. van Rhijn 
• Direct analysis of endogenous and synthetic steroid glucuronides in bovine urine by LC-MS/MS 
Patrick P.J. Mulder, Babette Beumer, Michel W.F. Nielen and Hans (J.) A. van Rhijn 
• Investigation of the metabolic path of nitrofurazonc in search of an alternative marker residue 
Tina Zuidema, Patrick P.J. Mulder, Bjorn J.A. Berendsen, Hans (J.) A. van Rhijn and Ron (L.) A.P. 
Hoogcnboom 
• A generic method for the quantitative analysis of penicillins using isotope dilution LC-MS/MS 
Patrick P.J. Mulder, Eric O. van Bcnnekom, Henri H. Heskamp, Tina Zuidema and Hans (J.) A. van 
Rhijn 
• Advanced multi-residue screening in food analysis using UPLC-ToF-MS 
Hans (J.) A. van Rhijn, Ccdric Bourgeon, Johan J.P. Lasaroms, Efrai'm Oostcrink and Dan McMillan 
• Production and characterization of fluoroquinolone incurred sample materials 
M.G. Pikkemaat, J.W.A. Elferink, P.P.J. Mulder, W.M.J. Beek and M.W.F. Nielen. 
• The ultimate veal calf reference experiment: histology and chemical analysis 
Maria Groot, Michel W.F. Nielen 
• Multiplex immunoassay for drug residues using the luminex xMAP technology 
M. Bienemann-Ploum, W. Haasnoot, H. Gercek and J. Du Pre 
• High throughput screening of hormonal activity in feed, calf urine and sports doping by yeast 
hormone bioassays 
RTKITT Rpnnr t 2 0 0 8 . 0 0 2 
T.F.H. Bovcc, R..L.A.P. Hoogcnboom, R.J.R. Heldsdingen, H.H. Hcskamp, A.R.M. Hamers, G. Bor, 
M.F.W. Nielen 
• Immunological detection of illegally administered growth hormones and - regulator in cattle 
T. Hcutmekers, M. Bremer, M.W.F. Nielen 
• Metalign as a tool for alignment of multiple hyphenated mass spectrometry data sets 
A. Lommen 
• Biosensor immunoassay-dirccted identification of fluoroquinolones by liquid chromatography 
electrospray quadrupolc time-of-flight mass spectrometry 
G.R. Marchcsini, H. Gercek, W. Haasnoot, M.W.F. Nielen 
• Metabolic activation and detection of dchydroepiandrostcronc (DHEA) using bovine liver S9 in 
combination with a sensitive yeast androgen assay 
J. Rijk, M. Groot, A. Pcijnenburg, T. Bovec, M. van Engelen, M.W.F. Niclcn 
• Changes in gene expression profiles of bovines treated with dchydroepiandrostcronc (DHEA) using a 
bovine DNA micro-array 
J. Rijk, M. Groot, A. Pcijnenburg, M.W.F. Nielen 
• Development of an integrated system for the detection of antimicrobial residues in slaughtered 
animals on EU MRL level: Nouws antibiotic test (NAT) 
H.J. van Egmond, J. Schouten, M. Rapallini, S. van Dijk, L. Kortcnocvcn, M.G. Pikkcmaat, H. Aarts, 
H. Stcgcman 
7.2 Publications in proceedings 
Publications in proceedings of the 5th International Symposium on Hormone and Veterinary Drug 
Residue Analysis; Antwerp, Belgium, 16-19 May 2006; Analytica Chimica Acta volume 586(2007): 
• Screening and confirmation criteria for hormone residue analysis using liquid chromatography 
accurate mass timc-of-flight, Fourier transform ion cyclotron resonance and orbitrap mass 
spectrometry techniques.M.W.F. Niclcn, M.C. van Engelen, R. Zuidcrcnt, R. Ramaker. 
• The determination of biurea: A novel method to discriminate between nitrofurazone and 
azodicarbonamide use in food products.P.P.J. Mulder, B. Beumer and J.A. Van Rhijn. 
• Confirmatory analysis of malachite green, leucomalachitc green, crystal violet and leucocrystal violet 
in salmon by liquid chromatography-tandem mass spectrometry. G. Dowling, P.P.J. Mulder, L. Regan, 
M.R. Smyth. 
• The ultimate veal calf reference experiment: Hormone residue analysis data obtained by gas and 
liquid chromatography tandem mass spectrometry 
M.W.F. Nielen, J.J.P. Lasaroms, M.L. Esscrs, M.B. Sanders, H.H. Heskamp, T.F.H. Bovee, J. van 
Rhijn, M.J de Groot. 




Multi-detector of corticosteroids in sports doping and veterinary control using high-resolution liquid 
chromatography/time-of-flight mass spectrometry. 
M.E. Touber, M.C. van Engelen, C. Georgakopoulus, J.A. van Rhijn, M.W.F. Niclcn. 
A rapid surface plasmon resonance (SPR) biosensor immunoassay for screening of somatrotropins in 
injection preparations 
T.H.J. Hcutmekers, M.G.E.G. Bremer, W. Haasnoot and M.W.F. Nielcn. 
• Dual biosensor immunoassay-dirccted identification of fluoroquinolones in chicken muscle by liquid 
chromatography clectrospray time-of-flight mass spectrometry 
G.R. Marchcsini, W. Haasnoot, P. Dclahaut, H. Gcrcek, M.W.F. Niclcn. 
• Biosensor immunoassay for flumequinc in broiler serum and muscle 
W. Haasnoot, H. Gercek, G. Cazcmier and M.W.F. Nielen. 
7.3 Other publications 
• Regarding the trends in analysis of veterinary drugs a review paper was published with the title 
'Trends in analysis of veterinary drugs and growth-promoting agents'. 
Authors: A.A.M. Stoiker, T. Zuidema and M.W.F. Nielen 
Journal: Trends in Analytical Chemistry (2007) volume 269 pages 67-979. 
7.4 Presentations 
• In July 2007 a Thai delegation was visiting the Netherlands. The delegation members were interested 
in the NRL/CRL organization structure. The delegation visited RIKILT and A.A.M. Stoiker gave a 
presentation regarding 'Official control of residues of veterinary drugs in food'. 
• In December 2007 a group of Brazilian expert (Brazilian LANAGRO managers and quality 
managers) visited RIKILT for a training in Quality Assurance, National Monitoring Plan, Quality 
Audits. During this training A. A.M. Stoiker gave a presentation titled: Analysis of antibiotics in 
animal products; screening and confirmation'. 
i
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8 Other NRL activities: organisation of proficiency tests 
In 2006 RIKILT has obtained accreditation for organizing proficiency tests focusing on veterinary drugs. 
See Annex IV for press release. 
To get answers to the questions 'How do RFL deal with MRL's?' and in particular the question 'How to 
deal with MRL substances occurring in a none-MRL matrix?' the following proficiency tests were 
organized by RIKILT: 
• The analysis of residues of (fluoro-)quinolones in muscle from broilers. This proficiency test started 
in 2005 and has been finalized in 2006. Results are described in RIKILT report 2006.003 of May 
2006 ' Inter-Laboratory Study for Quinoloncs in Poultry Muscle' by B.J.A. Bercndscn, J.A. van Rhijn. 
The summary is presented in Annex V. 
• The analysis of residues of penicillins in muscle and kidney from pigs. Results of this proficiency 
study are described in RIKILT report 2007.007 of April 2007 'Proficiency study for penicillins in 
porcine tissues' by B.J.A. Bcrcndsen and T. Zuidema. The summary is presented in Annex VI. 
• The analysis of residues of quinoloncs in egg. This proficiency test started in September 2007 and 
will be finalized in January 2008. Results of this proficiency study are described in RIKILT report 
2008.001 'Proficiency study for quinolones in egg' by B.J.A. Berendsen and A.A.M. Stolkcr. The 
summary is presented in Annex VII. 
A comparative study between VWA-Oost and RIKILT has been organized ad hoc on request of VWA-
Oost for the analysis of residues of dioxins using the CALUX. Results of this study arc presented in 
Annex VIII, in Dutch) 
RIKILT Report 2008.002 | 7 
Annex I Letter from VWA to EU regarding use of hair as a matrix for the 
analysis of beta-agonists 
| voedsel en waren autoriteit 
stibjscl 
Doc SANCO ; 
European Commission 
DG Health and Consumer Protection 
E3 Chemicals, contaminants, pesticides 
for the attention of ms. Dr. A.M. Blass-Rico 
Rue BeHiard 232 4/43 
6-10 49 BRUSSELS 
Belgium 
!006/3228 
Dear ms. Blass-Rico, Dear Ana Maria, 
During the Residues Expert Meeting in June 2006 a list of recommended values was 
distributed stating the concentrations proposed by the CRLs for control of substances 
without a MRL The Netherlands has commented or\ this document and in particular the 
proposed values for the A5 group (ß-agonisls) and the B2(e) group (NSAIDs) were too 
law in the opinion of the Metherlands to be routinely achievable at acceptable costs. 
We regret to note that our comments "egatding A5 and 62(e), although shared by 
several member states, were not adopted by the CRLs. 
On the occasion of the Residues Expert Meeting in May 2007 a revised document was 
made available (SANCO 2006/3228) which contains some particular statements 
regarding she use of hair as a matrix for the analysis of ß-agonists, which had not been 
Included in previous versions of this document. We strongly disagree with the CRLs 
opinion on the use of hair as a matrix suitable tor screening purposes only. 
With this tetter we want to draw your attention to this issue and wo kindly request to be 
informed of the Commission's position in this matter. 
We motivate the reasons for our disagreement below. 
The CRLs state, 'it is recoftimendablo to use hair for screening purposes only because 
of 'he risk of external confaminatön. When taking hair it is always recommended taking 
slso urine at the same time from 'he same animal.' In the corresponding table the matnx 
'hair is indicated as suitable for screening purposes only. 
date 
Mf I I » , 2007 
otir rcrctpfK* no. 
WW20W3I874 
handled fcy 
« t e w * <}•! <0)rtn« «S 07 
Many of the substances, which could be abused for growth promoting ars rapidly 
mstaboiised and excreted via urine and/or faeces. This results in a very short penod 
niter administration has been stopped during which residues of those substances can be 
detected. Unlike urine, hair is a matrix 'ram which the analyses do not rapidly deplete 
and effectively the active substances are accumulated in hair. As a result, compared to 
urine, residues remain detectable in hair for a considerably longer period after 
administration 
Veedssl en Wsrcn Autont*» 
LV«cfce T w ^ ' î i 
2V» SI. fei - i f»} 
I W C M B m H m j 
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voedsel en waren autoriteit 
The suggestion of the CRLs to use hair for screening only and sample urine "at the d'1t0 
same time from the same animal3 for confirmatory purooses. is in fact contra-productive J{*> •c'ih 20or 
our reference no. 
since in many cases urine will no longer contain the residue of interest and hence yield a vw/wosraiaN 
negative confirmatory result, while screening of hair samples of the same animal could pay« 
have indicated abuse of growth promoting agents. 7 '•? 
Hair as a matrix for detection of abuse of growth promoting agents has gained 
considerable interest in recent years. We are convinced that the CRLs are aware of this 
development. Not only for R-agonists hair has proven a suitable matrix for prolonged 
detection of abuse, also for detection of application of steroids and especially steroid 
esters, hair is currently considered an extremely suitable matrix. 
We have understood that the Commission intends to publish this document on the 
SANCO website. We are anxious that the comments of the CRLs with regard to the 
matrix hair, when included in the published version of this official document, will 
invalidate previous investigations carried out by the Netherlands in the Salmetcro! case 
of 'which you have been infonned previously. Those investigations have led to still on-
going legal follow-up against the owner of the treated animals. 
Regarding the judicial acceptability of results obtained from the analysis of hair we 
emphasise that in the Netherlands we have used hair as the matrix for confirmatory 
analysis. Those results were considered by the Dutch Court for Appeal tor trade and 
industry as perfectly acceptable legal prove of abuse of illegal substances. We therefore 
feci that the CRLs unrightfully invalidate hair as a legally acceptable matrix for control of 
the ban on the uso of growth promoting agents and hence, in our view this statement is 
incorrect, 
Last but not least we strongly emphasise that in our opinion it is not within the tasks of 
any CRL to judge the judicial acceptability of a particular matrix in legal procedures 
resulting from the detection of illegal use of growth promoting agents. We are therefore 
of the opinion that the remarks on suitability cf the matrix hair should be removed from 
the document. In our view, the CRLs, by including those statements in an official 
Commission document, jeopardise the enforcement of the ban on growth promoting 
agents. 
With kind regards. 
Voedsel enjßfejson Autoriteit 
LH. van der Sande 
Chief Inspector 
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Annex II Questionnaire: control of residues of antibiotics in cow milk 
Meeting Brussels 27 April 2007 
MEMBER STATE: 
l.What antibiotics arc authorised for use in milking cows (list) in your country? 
2. For what purposes are they authorised in milking cows? 
3. Describe briefly the strategy followed in the official laboratories for the control of residue of 
antibiotics in milk 
Example: 
1. Screening microbiological tests (which one, always the same?) 
2. What is the next step in case of suspected non-compliant results obtained with a screening method? 
Confirmation? Which method? 
3. Are any sample directly analysed by chemical methods (which one?) 
4. Which antibiotics-residues are the most frequently found in milk (ranking)? 
5. If possible, describe briefly the strategy followed in the dairies, farms or self-checking (autocontrols) 
laboratories for the control of residue of antibiotics in milk 
6. Which antibiotics-residues are the most frequently found in milk (ranking) in the case of self-
checking? 
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Annex III (in Dutch) Report from RIKILT to VWA regarding thiabendazole 
in milk 
Verslag van de toetsing door RIKILT van de door QLIP gebruikte methode voor de bepaling van 
Triclabcndazolc, Triclabcndazole-sulfon en Triclabcndazolc-sulfoxidc in zuivelproducten 
Inleiding 
In opdracht van de VWA is door RIKILT in hct kadcr van de NRL taak residuen 96/23/EC de methode 
voor de bepaling van Triclabcndazolc, Triclabcndazole-sulfon en Triclabcndazolc-sulfoxidc in 
zuivelproducten getoetst. Het bezoek hiertoe door Tina Zuidcma en Wim Traag vond plaats op 
donderdag 29 november (10.30- 15.30 h) bij het laboratorium van QLIP te Leusden. De 
gesprekspartners bij QLIP waren Dr. P. Stcketec en Dhr. R. de Kncgt. 
De aanleiding van deze opdracht was dat het COKZ in het kader van haar publieke taak ook officiële 
monsters voor analyse uitbesteedt cq. gaat uitbesteden aan QLIP. Ter voorbereiding op het bezoek is 
door RIKILT 6 dagen vóór het bezoek bij QLIP schriftelijk de gebruikte methode en relevante 
informatie opgevraagd. Helaas heeft QLIP niet aan dit verzoek gehoor gegeven, hierdoor was een goede 
voorbereiding door RIKILT niet mogelijk. 
Door de terughoudendheid van QLIP, zowel voorafgaand aan als tijdens het bezoek, en het ontbreken 
van de voor een goede beoordeling noodzakelijke details is het lastig om een goed gefundeerd oordcel 
met betrekking tot de gebruikte methode te geven. 
Observaties 
De stukken betreffende de gebruikte methode werden pas tijdens het bezoek ter inzage gegeven. De 
stukken bestonden uit: 
Algemene omschrijving van de toegepaste methode, zonder details betreffende gebruikte 
extractiemiddelen, procedure etc. 
Resultaten van een beperkte set (n=l 1) geanalyseerde monsters kaas, room en boter. 
Beperkte validatie gegevens. Deze gegevens zijn gegenereerd na rapportage van de monsters kaas, room 
en boter, in de periode tussen de vooraankondiging van het bezoek en het feitelijke bezoek. 
Na bestudering van de ter inzage verkregen stukken is een bezoek aan het laboratorium gebracht waar 
de metingen werden verricht. Het verzoek om ook het laboratorium te bezoeken waar de feitelijke 
opwerking (voorafgaand aan de meting) plaats vond werd geweigerd. 
Wel werden voorbeelden van extracten opgehaald en getoond. Inzage in labjournaals werd niet 
toegestaan. Er werd slechts informatie ter beoordeling beschikbaar gesteld betreffende de meting, 
chromatogrammen, ijklijnen en berekening. 
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Ad 1: 
Omdat het complete voorschrift niet ter beschikking werd gesteld kan er over de gevolgde procedure 
slechts een globaal oordeel gegeven worden. Het principe van de gevolgde methode lijkt goed. 
Ad 2: 
De resultaten van twee willekeurig door RIKILT gekozen positieve monsters kaas en boter zijn 
bestudeerd. 
De bijbehorende blanco controle monsters waren beiden positief (circa 25% van de gerapporteerd 
gehalten). Mogelijke oorzaken: 
Aanwezigheid van de component in het betreffende monsters (verkeerde keus blanco). 
Cross contaminatie (beide monsters werden voorafgegaan door een hoge standaard of een monster met 
toevoeging). 
In geen van de gevallen werd aantoonbaar gemaakt dat dit tijdens de analyse was opgevallen en /of er 
acties waren ondernomen. 
De gepresenteerde resultaten van de twee monsters laten zien dat in de extracten van deze monsters de 
identiteit van Triclabcndazol-sulfon bevestigd werd (conform de EU criteria, zoals beschreven in 
2002/657/EU. 
Monsters worden gerapporteerd via c-mail zonder disclaimers. 
Ad 3: 
De beperkte validatie betreft het analyseren van een beperkte set blanco monsters en blanco monsters 
met toevoeging en de resultaten van de duplo analyse van een beperkte set positieve monsters. 
De beperkte validatie is gericht op een kwantitatieve bevcstigingsmethode, voornamelijk omvattend 
juistheid, herhaalbaarheid, binncnlab reproduceerbaarheid en lineariteit. 
De resultaten van de beperkte validatie geven onvoldoende basis voor het betrouwbaar kunnen 
kwantificeren (o.a. enorme spreiding in juistheid, lineariteit voldoet niet). Wel lijkt de methode geschikt 
om de identiteit, conform geldende EU criteria, van Triclabendazole en de twee metabolieten te 
bevestigen. 
De spreiding van de duplo analyses van de positieve monsters lijkt goed. 
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Conclusie 
Door de terughoudendheid van QLIP, zowel voorafgaand aan als tijdens het bezoek, en het ontbreken 
van de, voor een goede beoordeling noodzakelijke details, is het lastig om een goed gefundeerd oordcel 
met betrekking tot de gebruikte methode te geven. 
Er kan niet geconcludeerd worden dat er een goed beschreven methode op het lab gebruikt wordt. 
De monsters zijn gerapporteerd met een niet uitontwikkelde en niet gevalideerde methode. 
Over de extractie, de bereiding van de standaarden en de kwaliteitscontrole monsters kan geen oordcel 
gegeven worden omdat verzoek van RIKILT om dit te kunnen waarnemen, werd afgewezen. 
Cross contaminatie tijdens opwerking/meting/analysc kan niet uitgesloten worden. 
De identiteit van Triclabcndazol-sulfon is in de extracten van de twee nader door RIKILT bekeken 
monsters bevestigd. 
03-12-2007, Tina Zuidema, Wim Traag 
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Annex IV Press release regarding RIKILT accredited for organization of 
proficiency tests 
Persbericht RIKILT- Instituut voor Voedselveiligheid, Wageningen UR 
10 januari 2007 
RIKILT ontvangt accreditatie voor ringonderzoeken dierbehandelingsmiddelen 
Onlangs heeft RIKILT - Instituut voor Voedselveiligheid (onderdeel van Wageningen UR) een 
accreditatie ontvangen voor het uitvoeren van ringonderzoeken voor de analyse van 
dierbehandelingsmiddelen. RIKILT is daarmee het eerste instituut in Nederland dat op dit gebied 
een accreditatie voor ringonderzoeken ontvangt. 
Een accreditatie is een onafhankelijk getoetst "bewijs van goed kunnen" voor een organisatie. In dit 
specifieke geval krijgt RIKILT een formele erkenning voor de uitvoering van ringtesten op het 
gebied van dierbehandelingsmiddelen (onder ILAC G13:2000) zoals bijvoorbeeld 
diergeneesmiddelen, groeibevorderaars en antibiotica. Een ringtest is een belangrijk middel om de 
prestaties van laboratoria met elkaar te vergelijken en daarmee gezamenlijk op een hoger plan te 
krijgen. RIKILT was al geaccrediteerd voor de analyse van een groot aantal stoffen uit deze groep. 
De accreditatie sluit goed aan op de nieuwe rolverdeling tussen de overheid en het bedrijfsleven. 
Deze houdt in dat niet de overheid producten in de markt controleert, maar dat bedrijven zelf de 
verantwoordelijkheid nemen voor het voldoen aan normen en regels. De overheid zal zich meer 
toeleggen op het toezicht op deze controlerol van het bedrijfsleven, het zogenaamde Toezicht op 
Controle'. Doordat RIKILT de accreditatie op ringonderzoeken heeft ontvangen, wordt het voor de 
laboratoria die meedoen aan de ringtesten mogelijk om hun prestatieniveau aantoonbaar te 
waarborgen. 
RIKILT had al een accreditatie op basis van ISO 17025 voor testlaboratoria. 
De testen die hieronder vallen, staan vermeld op de website van de Raad voor Accreditatie. 
Noot voor de redactie: 
Voor informatie over dit bericht kunt u contact opnemen met Jeannette Leenders van RIKILT, 
telefoon 0317-475402. 
RIKILT - Instituut voor Voedselveiligheid is onderdeel van Wageningen Universiteit & 
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Annex V Summary report 2006.003: Inter-Laboratory study for quinolones 
in poultry muscle 
The intcr-laboratory study for quinolones in poultry muscle was performed in accordance with ISO/1EC 
Guide 43-1 and 43-2 and ILAC-G13. 
For this intcr-laboratory study, three test materials were prepared: 
• A blank material (A); 
• A material containing ciprofloxacin and enrofloxacin, the sum of both being just below the MRL, 
danofloxacin and difloxacin both at levels of about the MRL (B); 
• A material containing ciprofloxacin and enrofloxacin, the sum of both being just above the MRL, 
danofloxacin and difloxacin at levels of approximately 0.5*MRL (C); 
Homogeneity and satisfactory stability of the materials was demonstrated. 
Thirty four laboratories were invited to participate in the inter-laboratory study for quinolones in poultry 
muscle of which seventeen laboratories, i.e. 50%, subscribed. Each laboratory received six randomly 
coded samples including one sample of material A, three samples of material B and two samples of 
material C. The laboratories were asked to analyze the samples in duplicate. 
Fifteen laboratories managed to submit results that could be included in the evaluation. The majority of 
those laboratories applied a validated and accredited method for the analysis of quinolones in poultry 
muscle. 
Three laboratories used a method that did not include all the quinolones that are registered for 
medication in poultry in the EU. 
The laboratories applied different methodologies. Four different sample clean-up procedures can be 
distinguished: 
• Solid Phase Extraction (SPE): using reversed phase (CI8 or OASIS® HLB) or reversed phase 
combined with cation exchange interaction (SDB-RPS); 
• Filtration (0.45 urn) without any further purification; 
• Ultrafiltration (30 kD) without any further purification; 
• Partial evaporation of the solvent followed by dilution without further purification. 
Two detection techniques were applied for the quantitative and confirmatory analysis of quinolones in 
poultry muscle: LC-MS/MS and LC-(UV)-FLU. 
In accordance with the definition of the MRL, all laboratories considered the sum of enrofloxacin and 
ciprofloxacin in classifying the results as either compliant or non-compliant. 
Most participating laboratories determined values for CCa and CCß and, hence, the majority already 
complies with the requirements of Commission Decision 2002/657/EC regarding CCa and CCß that 
apply for registered veterinary drugs as from the 1st of August 2007. 
Some laboratories reported values for CCa and CCß below the MRL. This is not in compliance with the 
definition of CCa and CCß for compounds for which a permitted limit is established. For some 
laboratories the reported values for CCa and CCß are not in agreement with the reproducibility of the 
analysis calculated from the reported results in this inter-laboratory study. In both cases, reconsideration 
of the value of CCa and CCß could be necessary. 
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No false positive or false negative results occurred in this inter-laboratory study. 
For all compounds and materials a considerable variation of the reported results is observed. In some 
cases the lowest and the highest value reported differ by a factor 40. In this intcr-laboratory study a 
considerable number of results is classified as questionable or unsatisfactory. Those results could not be 
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explained based on the applied detection technique. However, it is observed that filtration (0,45 urn) as 
sample preparation technique, without any further purification is not suitable for the analysis of 
quinolones in poultry muscle. 
For each laboratory, the performance with respect to accuracy, reproducibility, false positive and false 
negative results was expressed in a laboratory performance score. Only 60% of the laboratories obtained 
the maximum score. 
Based on the results, it is concluded that extra effort in the optimization of analytical methods for the 
analysis of quinolones in poultry muscle is urgently required: 
• Danofloxacin, difloxacin and sarafloxacin should be included in the methods of analysis of 
quinolones by all laboratories, because those compounds arc registered for medication in poultry in 
the EU; 
• Reconsideration of numerical values determined for CCa and CCß may be necessary in some cases; 
• An effort should be made regarding the quantitative analysis of all quinolones in poultry muscle 
with respect to the accuracy and the reproducibility. 
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Annex VI Summary of report 2007.007: Proficiency study for penicillins in 
porcine tissues 
The proficiency study for penicillins in porcine tissues was organized in accordance with ISO/IEC 
Guide 43-1 and 43-2 and ILAC-G13, and performed under accreditation. 
For this proficiency study, four test materials were prepared: 
• A blank porcine muscle material (M-A); 
• A porcine muscle material containing about 200 ug/kg cloxacilline and a trace of ampicillin (M-B); 
• A blank porcine kidney material (K-A); 
• A porcine kidney material containing about 100 ug/kg cloxacillin, 30 ug/kg ampicillin and about 20 
ug/kg penicillin G (K-B). 
During homogeneity testing, all materials proved to obtain sufficient homogeneity for proficiency 
testing. 
Forty-four laboratories were invited to participate in the proficiency study for penicillins in porcine 
tissues of which 21 laboratories, i.e. 48%, subscribed. Each laboratory received six randomly coded 
samples. The laboratories were asked to analyze the samples in duplicate according to their own 
laboratory procedures. It was mentioned that maintaining the stability of the samples (storage and 
pretreatment) was part of the proficiency test. 
Eighteen laboratories managed to submit results within the timeframe of the study of which 15 reported 
quantitative results for both the muscle and the kidney samples. Two laboratories reported only results 
for the muscle samples and one laboratory only reported screening results. The majority of the 
laboratories applied a validated and accredited method for the analyses. 
The stability of penicillins can, according to literature, be maintained by storing the samples below -70 
°C. Within this proficiency study a stability experiment at -20 °C was carried out. This stability study 
showed a degradation of ampicillin, cloxacillin and penicillin G above 75 % in the kidney material 
during the timeframe of the proficiency study. The penicillins in kidney proved to be instable even after 
stabilization by buffering the material at pH=6. Therefore, the kidney samples are not suited for 
evaluation purposes. 
During storage at -20 °C the muscle material showed a degradation of 31 % for ampicillin and 27% for 
cloxacillin was observed. However, the penicillins in the muscle material showed to be stable at -20 °C 
after buffering at pH=6. Therefore, the muscle materials are suitable for this proficiency study, because 
maintaining the stability was mentioned as a part of this proficiency study. 
In the stability study a degradation of penicillins during storage at -20 °C was observed, which is in 
agreement with literature. According to the information supplied by the participants, four laboratories 
stored their samples at -20 °C. Therefore it can be assumed that the samples of these laboratories were 
instable during the timeframe of the proficiency study. However, no statistically significant difference 
was observed between the results of the laboratories that stored the samples at -20 °C and the results of 
the laboratories that stored the samples at a temperature below -70 °C. Therefore, also the stability of 
the samples, even if stored at -70°C can be questioned. Probably, other factors than storage temperature 
are of influence on the stability. Based on these observations, the correctness of the calculated assigned 
values (consensus values) can be questioned. Therefore, this proficiency study is evaluated for 
information only. 
The participants applied different methodologies for carrying out the analysis of penicillins in porcine 
tissues. Almost every laboratory applied identical procedures for muscle and kidney. 
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The mainly applied extraction solvent is a phosphate buffer at pH 8 to 9, sometimes combined with an 
organic solvent. The majority of laboratories applied Solid Phase Extraction as a sample clean up 
technique. In all cases a CI8 material or OASISTM HLB was used as stationary phase. 
Two laboratories applied a derivatization procedure. One laboratory applied a derivatization at the end 
of the sample clean up procedure using benzoic acid anhydride in combination with triazole and 
mercury chloride solution. The other laboratory applied a derivatization using pipcridin during the 
extraction. 
For all compounds and materials a considerable variation of the reported results is observed, possibly 
caused by the instability of the materials. No relations were observed between the laboratories results 
and the storage temperature, storage time (date of analysis) or a combination of these factors. 
Based on the results, it is concluded that additional effort is needed to develop a robust method for the 
analysis of penicillins in porcine tissues. Stability of the compounds during storage seems to be an 
underestimated factor. Based on the results of the stability study, adequate storage and/or the use of a 
stabilization procedure at the time of arrival of the samples is required for obtaining reliable results. 
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Annex VII Summary of report 2007.001 : Proficiency study for quinolones in 
egg 
The proficiency study for quinolones in egg was organized in accordance with ISO/IEC Guide 43-1 and 
43-2 and ILAC-G13, and under accreditation. 
For this proficiency study, four test materials were prepared: 
• A blank egg material; 
• A blank egg material containing possibly interfering compounds to test the selectivity of the applied 
methods; 
• An egg material containing about 70 ug/kg oxolinic acid (incurred) and about 50 ug/kg of both 
ciprofloxacin and cnrofloxacin (spiked); 
• An egg material containing about 125 ug/kg flumequine (incurred). 
During homogeneity testing, all materials proved to obtain sufficient homogeneity for proficiency 
testing. The stability test demonstrated that no significant loss of any of the compounds occurred during 
the timescale of the proficiency test. 
Eighteen laboratories subscribed for participation in the proficiency study quinolones in egg of which 
three are National Reference Laboratories. Fifteen laboratories managed to submit valid results within 
the timeframe of the stability study. Five of the participating laboratories applied a validated method 
which was accredited in all cases. 
The minority of participants applied a validated method for the analysis of quinolones in egg. Only three 
laboratories reported values for CCa and CCß. It is noted that reported values for CCa and CCß 
severely differ among the laboratories. Most likely these differences exist due to different interpretation 
of the regulations. From the reported values of CCa it is concluded that some laboratories calculated 
CCa based on a self set MRL, others applied the zero tolerance approach. From this it is concluded that 
laboratories cope in very different ways with the non existence of MRL values for quinolones in egg 
whilst MRLs are set for other matrices. Discussion on this issue resulting in clear legislation is of main 
importance for obtaining a uniform approach within Europe. 
None of the laboratories detected any quinolones neither in the blank material nor in the material 
containing possibly interfering compounds. It is concluded that the applied methods arc all satisfactory 
specific for the quantitative and confirmative analysis of ciprofloxacin (CIF), cnrofloxacin (ENF), 
oxolinic acid (OXA) and flumequine (FLU) in egg. 
One laboratory detected norfloxacin in the two samples that contain quinolones. This is considered as a 
false positive result. One laboratory did not detect CIF in the material that contains CIF, whilst CIF was 
included in their method. This is considered as a false negative result. 
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The laboratory's performance for the materials containing quinolones is summarized in Table 1. 
Table I. Summary ojjhejaboratorv's performance of the materials containing atiinolonens 
Compound Assigned value (X) Uncertainty of X No. of labs that _J^£^££SS^{ä£toj[vjre^^ 





















For OXA and FLU all reported results were satisfactory. For CIF and ENF some questionable and 
unsatisfactory results arc observed. The occurrence of questionable or unsatisfactory results could not be 
explained by the applied detection or sample preparation technique. 
However, 75% of the total of calculated za-scores is between -0.5 and 0.5 indicating excellent accuracy 
for most laboratories. Therefore it is concluded that the performance of most laboratories is excellent 
regarding the quantification of quinolones in egg. 
One laboratory detected norfloxacin in one of the duplicate analysis of both samples of material Egg-03. 
This is considered as a false positive result. The same laboratory did not detect CIF in the samples of 
material Egg-03. This is considered as a false negative result. 
The performance with respect to accuracy, false negative and false positive results was expressed in a 
laboratory performance score for each laboratory. In this 73% of the laboratories obtained the maximum 
score. 
Based on the results of this proficiency study it is concluded that: 
• regarding B group substances for which no MRL is set in a specific matrix, legislation should be 
clarified to obtain a uniform way for the determination of CCa and CCß within the EU and with this 
a uniform way of characterizing the samples in terms of compliant and non compliant.. 
• for most laboratories extra effort is needed to validate the analysis of quinolones in egg to be able to 
report results including a value for measurement uncertainty. 
• extra effort is needed by some laboratories to include oxolinic acid in the method of analysis for 
quinolones in egg because, officially, oxolinic acid is the only quinolone registered for medication 
of laying hens in the EU and for which an MRL is established. 
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Annex VIII (in Dutch) Report comparative study between VWA-Oost and 
RIKILT for the analysis of residues of dioxins using the CALUX 
Aanleiding 
Op verzoek van de VWA werd op 30-01-2006 op ad hoc basis cen rondzendondcrzock voor bepaling 
van dioxinen met Calux georganiseerd. Er werden een viertal monsters uitgezocht die op basis van de 
resultaten van de GC-HRMS analyse blanco waren of hoeveelheden dioxinen bevatten die net boven 
de norm liggen. Het betrof twee monsters varkensvet en twee monsters voer. 
Het verzoek aan de VWA is om de verstrekte monsters te onderzoeken op de aanwezigheid van 
dioxinen met de Calux test en de monsters te classificeren als negatief in geval geen dioxinen werden 
aangetroffen, of verdacht wanneer de aanwezigheid van dioxinen werd aangetoond. 
Methoden 
Bereiding monsters-
De opzet van de ringtcst is beperkt door de geringe hoeveelheid monstcrmatcriaal die beschikbaar was. 
Het doel was de positieve monsters in duplo te verstrekken en de negatieve monsters in enkelvoud. 
Voor het varkensvet is dat echter niet mogelijk gebleken omdat er te weinig materiaal voorhanden was, 
dit monster is dan ook in enkelvoud verstrekt zodat in totaal 5 monsters aan VWA werden aangeboden 
(tabel 1). 
Tabel 1: Monsters dierlijk vet en diervoeder verstrekt aan VWA-Laboratoriwn Oost ten behoeve van een ad hoc 
































Varkensvetten zijn bij 70°C gesmolten, gehomogeniseerd en daarna in de monsterpotten gcpipcttccrd. 
Voermonsters zijn met een spatel gedurende ca 5 min geroerd om te homogeniseren en daarna 
ingewogen in de monsterpotten. 
De monsters zijn verdeeld in aliquots zoals weergegeven in tabel 1 en voorzien van unieke RIKILT 
nummers. De monsters zijn op 30-01-2006 aan M. van Brakel VWA overhandigd, een 
overdrachtsformulier is opgemaakt en getekend. Het mondelinge verzoek aan de heer van Brakel is 
gedaan om, indien mogelijk, de monsters in duplo te analyseren. 
Onderzoeksmethode VWA 
De DR-CALUX bioassay van BioDetection Systems (BDS) is toegepast, met enkele modificaties. Het 
vet wordt geëxtraheerd met hexaan/diethylether, waarna een clean-up volgt over een zwavelzure 
silica-kolom. De modificaties behelzen een "voorverbranding" met zwavelzuur, wanneer veel vet moet 
worden ingewogen en langere zwavelzure kolommen dan BDS voorschrijft. 
Het verkregen extract wordt vervolgens met een bioassay bepaald, waarbij op iedere plaat een 
calibratielijn TCDD wordt meegenomen. Aan de hand van deze calibraticlijn worden de monsters 
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middels het gevonden gehalte beoordeeld als negatief of verdacht. Voor de beoordeling van dierlijk vet 
is uitgegaan van de 0,6 ng TEQ/ g vet (acticdrcmpel voor varkens) en voor veevoer van 0,5 ng TEQ/g 
product (actiedrempcl veevoer van plantcnmateriaal). De monsters zijn in duplo geanalyseerd. 
Resultaten 
Op 02-02-2006 zijn de resultaten van VWA-Laboratorium Oost gerapporteerd (zie bijlage 1). De 
resultaten zijn vermeldt in tabel 2. 
Tabel 2: Resultaten van de screening op dioxinen met behulp van Calux van de monsters dierlijk vet en 
diervoeder 
Matrix RIKILT nr Resultaat Resultaat 








Blanko varkensvet 164854 
Varkensvct 164856 




Er blijkt een goede overeenstemming tussen de resultaten van de GC-HRMS (RIKILT) en de Calux 
(VWA-Oost). 
Bijlage 1 
Rapportage van VWA-Oost 
Rapportageformulier 
Ad hoc inter-laboratoriumonderzoek dioxinen 
Contactpersoon VWA-Oost: 
Datum (dd-mm-yy): 
E.A.J. van der Made 
02-02-06 
Resultaten 
Bij rapportage dienen de geldende normen voor respectievelijk dierlijk vet en diervoeder te worden 
gehanteerd. 




















Duplo: twee aparte analyses, dus twee inwegen per monster. 
Welke criteria zijn toegepast op de resultaten bij classificeren als "negatief* of verdacht"? 
Voor de beoordeling van dierlijk vet is uitgegaan van de 0,6 ng TEQ/ g vet (acticdrcmpcl voor 
varkens) en voor veevoer van 0,5 ng TEQ/g product (acticdrcmpcl veevoer van plantcnmatcriaal). 
Informatie over de methode 
Welke methode werd toegepast? 
Geef svp een korte omschrijving van de methode (analyse inclusief monstcrvoorbcwcrkingsproccdurc) 
De DR-CALUX bioassay van BioDetection Systems (BDS) is toegepast, met enkele modificaties. Het 
vet wordt geëxtraheerd met hexaan/dicthylether, waarna een clcan-up volgt over een zwavelzure 
silica-kolom. De modificaties bchclscn een "voorverbranding" met zwavelzuur, wanneer veel vet moet 
worden ingewogen en langere zwavelzure kolommen dan BDS voorschrijft. 
Het verkregen extract wordt vervolgens met een bioassay bepaald, waarbij op iedere plaat een 
calibratielijn TCDD wordt meegenomen. Aan de hand van deze calibraticlijn worden de monsters 
middels het gevonden gehalte beoordeeld als negatief of verdacht. 
Is de methode gevalideerd en zo ja voor welke matrices? 
Gebruik s.v.p. tabel 2 voor beantwoording met hieronder eventuele opmerkingen. 
De methode voldoet aan de eisen zoals deze in de Richtlijnen 2002/69/EG en 2002/70/EG voor 
bioassays zijn gesteld, daarnaast heeft er een cross-validatic met BioDetection Systems (BDS) 
plaatsgevonden. Voor veevoer zijn aanvullende metingen verricht door verschillende analisten op 
verschillende dagen op drie niveau's (0,375 - 0,75 - 1,5 pg TEQ/g product, n= resp. 8, 11, 6). Uit F-
en t-toets bleek dat het laagste niveau niet samengevoegd mocht worden met de twee hogere. De 
spreiding op een niveau van 0,75 pg TEQ/g product bedraagt 0,14 pg TEQ/ g product. Dit levert een 
meetonzekerheid (binnenlaboratoriumreproduceerbaarheid) op van 0,39 pg TEQ/g product op een 
niveau van 0,75 pg TEQ/g product. 
Tevens wordt ieder zestiende monster ter controle gecontroleerd door een HR-GCMS-bepaling. Tot op 
heden zijn geen vals negatieve resultaten na bevestiging met HR-GCMS voorgekomen. 
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Werd de methode gevalideerd conform Commissie Beschikking 2002/657/EC? 
Zo ja, geef s.v.p. de CCß. 
Zo nee, welke benadering werd dan toegepast voor validatie en wat is de CCß of LoD? 
Neen, de methode is niet gevalideerd conform 2002/657/EC . De LoD is volgens BDS 0,3 pM/wcll, 
zodat de methode voor varkensvet een LoD heeft van 0,14 pg TEQ/g vet en 0,07 pg TEQ/g product 
voor veevoer. 
Is de methode geaccrediteerd en zo ja voor welke matrices? 
Gebruik s.v.p. tabel 2 voor beantwoording met hieronder eventuele opmerkingen. 
De methode is niet geaccrediteerd. 









































0,07 pg TEQ/ g 
product 
0,14pgTEQ/gvct 
Stuur de resultaten zo spoedig mogelijk, bij voorkeur per e-mail naar: 
Drs. J.A. van Rhijn, RIKILT - Instituut voor voedselveiligheid 
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